Company intelligence / Profile preview

Yaeyama Shokusan

Ishigaki, Okinawa Prefecture, Japan

Ownership: Private
Development stage: Other

Overview

Yaeyama Shokusan grows, extracts, and commercializes Yaeyama Chlorella, a freshwater microalga sourced from Ishigaki Island, Japan, notable for very high protein, chlorophyll, vitamins, minerals, and a proprietary process for cell wall disruption for absorption; marketed globally with Kosher certification and patent-protected cultivation methods. Not a drug company, so no clinical trial results.

Therapeutic areas: GastroenterologyOtherImmunologyMetabolic Disorders
Modalities: ProteinDietary supplementMicrobial therapy
Industry: Food & Nutrition

Partnerships

Euglena (distribution, possible manufacturing)local distributors in Israel (Kosher market)Source NaturalsGreen Nutritionalsother supplement marketers

Beyond the preview

Go deeper on Yaeyama Shokusan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yaeyama Shokusan.

Explore the full profile